This is one hell of a report.
They blew away the numbers of a year ago, and although they spent more than double the expenses to advertise their new tablets(which is a good thing), these numbers are phenominal and can't be ignored any longer. I don't care if this is the OTC or NASDAQ, it's time to shine. This company is for real, as most of us here already knew.